Third generation oral contraceptives and risk of venous thrombosis: meta-analysis

No abstract is available for this paper.

• Publication year

  2001

• Venue

  British medical journal

• Publication date

  2001-07-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bmj.323.7305.131PMID 11463678PMCID PMC34722
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral contraceptives and the risk of venous thrombosis.

  2001cited by this paper
• washington Bush boosts research funds despite general austerity

  2001cited by this paper
• maastricht Study on risks of third Wim Weber generation pill “kept secret by industry”

  2001cited by this paper
• Study on risks of third generation pill "kept secret by industry".

  2001cited by this paper
• Venous thromboembolism and combined oral contraceptives: does the type of progestogen make a difference?

  2000cited by this paper
• Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis

  2000cited by this paper
• Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.

  2000cited by this paper
• A comparison of the risks of venous thromboembolic disease in association with different combined oral contraceptives.

  2000cited by this paper
• Scoring the quality of clinical trials.

  2000cited by this paper
• Scoring the quality of clinical trials.

  2000cited by this paper
• Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risks.

  1999cited by this paper
• Interaction Between the G 20210 A Mutation of the Prothrombin Gene and Oral Contraceptive Use in Deep Vein Thrombosis

  1999cited by this paper
• The differential risk of oral contraceptives: the impact of full exposure history.

  1999cited by this paper
• Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnostic suspicion and referral bias.

  1999cited by this paper
• Smoking and use of oral contraceptives: impact on thrombotic diseases.

  1999cited by this paper
• Oral contraceptives and venous thromboembolic disease. Analyses of the UK General Practice Research Database and the UK Mediplus database.

  1999cited by this paper
• The hazards of scoring the quality of clinical trials for meta-analysis.

  1999cited by this paper
• The risk of venous thromboembolism in users of postcoital contraceptive pills.

  1999cited by this paper
• The Transnational Study on Oral Contraceptives and the Health of Young Women. Methods, results, new analyses and the healthy user effect.

  1999cited by this paper
• Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database.

  1999cited by this paper
• The aftermath of a pill scare: regression to reassurance.

  1999cited by this paper
• Venous thromboembolism among new users of different oral contraceptives.

  1999cited by this paper
• Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis.

  1999cited by this paper
• The transnational study on oral contraceptives and the health of young women. Methods, results, new analyses and the healthy user effect

  1999cited by this paper
• Interpretations. The aftermath of a pill scare: regression to reassurance

  1999cited by this paper
• Conflict of interest in the debate over calcium-channel antagonists.

  1998cited by this paper
• Conflict of interest in the debate over calcium-channel antagonists.

  1998cited by this paper
• The risks of venous thromboembolic disease among German women using oral contraceptives: a database study.

  1998cited by this paper
• Oral contraceptives and venous thromboembolism. A case-control study.

  1998cited by this paper
• Third Generation Oral Contraceptives and Heritable Thrombophilia as Risk Factors of Non-fatal Venous Thromboembolism

  1998cited by this paper
• Newer oral contraceptives and the risk of venous thromboembolism.

  1998cited by this paper
• Resistance to activated protein C, highly prevalent amongst users of oral contraceptives with venous thromboembolism

  1998cited by this paper
• Oral contraceptives and venous thromboembolic disease: the findings from database studies in the United Kingdom and Germany.

  1998cited by this paper
• Rationing health care

  1997cited by this paper
• The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.

  1997cited by this paper
• First-time use of newer oral contraceptives and the risk of venous thromboembolism.

  1997cited by this paper
• Confounding and indication for treatment in evaluation of drug treatment for hypertension

  1997cited by this paper
• The influence of thrombotic risk factors when oral contraceptives are prescribed

  1997cited by this paper
• Population-based study of risk of venous thromboembolism associated with various oral contraceptives.

  1997cited by this paper
• The influence of thrombotic risk factors when oral contraceptives are prescribed a control‐only study

  1997cited by this paper
• Third-generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation.

  1997cited by this paper
• Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study

  1996cited by this paper
• Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens.

  1996cited by this paper
• Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease

  1996cited by this paper
• Selective prescribing of third generation oral contraceptives (OCs).

  1996cited by this paper
• Oral contraceptives and thrombotic diseases: impact of new epidemiological studies.

  1996cited by this paper
• The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.

  1996cited by this paper
• Oral contraceptives and thrombotic diseases: impact of new epidemiological studies.

  1996cited by this paper
• Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.

  1995cited by this paper
• Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.

  1995cited by this paper
• Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

  1995cited by this paper
• Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

  1995cited by this paper
• FLUOROURACIL AND FOLINIC ACID IN COLON CANCER

  1995cited by this paper
• Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

  1995cited by this paper
• Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis: Methods for Quantitative Synthesis in Medicine

  1994cited by this paper
• A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis.

  1994cited by this paper
• [Epidemiologic research].

  1970cited by this paper
• Contraception

  1924cited by this paper

• Drug-associated deep vein thrombosis: a disproportionality analysis of the FDA adverse event reporting system (FAERS) database.

  2026cites this paper
• Knowledge Assessment about Deep Vein Thrombosis among Women Using Combined Oral Contraceptive Pills

  2025cites this paper
• Thrombophilia assessment: Experience of the hematology laboratory of IBN ROCHD AMC of Casablanca

  2025cites this paper
• Migraine in women: a review

  2025cites this paper
• Anticoncepção hormonal combinada

  2025cites this paper
• Clinical strategies for management of abnormal uterine bleeding: hormonal and nonhormonal interventions in women at risk for venous thromboembolism.

  2025cites this paper
• Examining postpartum anticoagulation practices: An international survey of healthcare providers.

  2024cites this paper
• Ischemic Stroke in Women: Understanding Sex-Specific Risk Factors, Treatment Considerations, and Outcomes

  2024cites this paper
• Systemic Risk Factors in Branch Retinal Vein Occlusion: a Comprehensive Review.

  2024cites this paper
• Prevention and Management of Venous Thromboembolism

  2024cites this paper
• Cerebral venous sinus thrombosis due to desogestrel intake in a young lady: A case report

  2024cites this paper
• Venous Thromboembolism and Estrogen-Containing Gender-Affirming Hormone Therapy

  2023cites this paper
• GRADE notes 3: Two approaches to assess industry sponsorship bias used by two Dutch Guidelines organizations.

  2023cites this paper
• Effects of rimegepant 75 mg daily on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate in healthy female participants

  2023cites this paper
• Withholding of Hormone Replacement Therapy prior to total joint arthroplasty surgery to reduce the risk of post-operative thromboembolic events: is it justified? - A systematic review of Clinical Practice Guidelines.

  2023cites this paper
• The effect of hormonal contraceptive therapy on clinical laboratory parameters: a literature review

  2023cites this paper
• Thrombose veineuse profonde des membres inférieurs

  2023cites this paper
• Investigating cardiovascular risk in premenopausal women on oral contraceptives: Systematic review with meta-analysis

  2023cites this paper
• Low Thrombin Generation in Users of a Contraceptive Containing Estetrol and Drospirenone

  2022cites this paper
• Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

  2022cites this paper
• Oral contraceptives and stroke: Foes or friends.

  2022cites this paper
• [The risk-benefit balance of estrogen-progestogen hormonal contraception].

  2022cites this paper
• Evidence for stratified conflicts of interest policies in research contexts: a methodological review

  2022cites this paper
• Albumin, Oral Contraceptives, and Venous Thromboembolism Risk in Astronauts.

  2022cites this paper
• Risk Factors for Revision or Rerupture After Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis

  2022cites this paper
• Spironolactone Versus Oral Contraceptive Pills in the Treatment of Adolescent Polycystic Ovarian Syndrome: A Systematic Review

  2022influential citation
• Hormonal therapies and venous thrombosis: Considerations for prevention and management

  2022cites this paper
• Hormone replacement therapy in women with history of thrombosis or a thrombophilia

  2022cites this paper
• Combined oral contraceptives: Why, when, where?

  2022cites this paper
• Scientific Integrity

  2021cites this paper
• Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk

  2021cites this paper
• Prospecção Tecnológica dos Métodos Contraceptivos como Ferramenta de Análise da Responsabilidade Cultural na Maternidade – Os Dados a Favor da Transformação Social

  2021cites this paper
• Oral contraceptives increase platelet microparticle levels in normal-weight women with polycystic ovary syndrome

  2020cites this paper
• Contraception et maladies auto-immunes

  2020cites this paper
• “What will happen in the future?” A personal VTE journey

  2020cites this paper
• The Handbook of Contraception: Evidence Based Practice Recommendations and Rationales

  2020cites this paper
• Hormonal Contraceptives: Communication for Risk Awareness and Informed Choice, or a Public Scare?

  2020cites this paper
• Location-specific risk factors for intracerebral hemorrhage

  2020cites this paper
• Hormonal Contraceptives and the Risk of Venous Thrombosis

  2020cites this paper
• The Contraceptive Vaginal Ring

  2020cites this paper
• Iron-deficiency and estrogen are associated with ischemic stroke by up-regulating transferrin to induce hypercoagulability

  2019cites this paper
• 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

  2019cites this paper
• Sexualhormone

  2019cites this paper
• Estrogen, migraine, and vascular risk

  2018cites this paper
• Effects of different hormonal contraceptives in women's blood pressure values.

  2018cites this paper
• Contraceptive Strategies in Women With Heart Failure or With Cardiac Transplantation

  2018cites this paper
• Sex hormones and venous thromboembolism - from contraception to hormone replacement therapy.

  2018cites this paper
• Systematic review and meta-analysis of the association of combined oral contraceptives on the risk of venous thromboembolism: The role of the progestogen type and estrogen dose.

  2018cites this paper
• The effects of oral contraceptive usage on thrombin generation and activated protein C resistance in Saudi women, with a possible impact of the body mass index

  2018cites this paper
• Analysis of Risk Factors of Stroke and Venous Thromboembolism in Females With Oral Contraceptives Use

  2018cites this paper
• Contraceptive Management for Women Who Are at High Risk of Thrombosis.

  2018cites this paper
• A systematic review and meta‐analysis of venous thrombosis risk among users of combined oral contraception

  2018cites this paper
• [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].

  2018cites this paper
• FSRH Guideline (January 2019) Combined Hormonal Contraception

  2018cites this paper
• Comment prescrire une contraception orale chez l’adolescente ?

  2018cites this paper
• Industry sponsorship and research outcome.

  2017cites this paper
• Combined hormonal contraception and the risk of venous thromboembolism: a guideline.

  2017cites this paper
• ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists

  2017cites this paper
• High salt intake does not aggravate glucose dysregulation and dyslipidemia induced by estrogen-progestin oral contraceptive.

  2017cites this paper
• Thrombophilia Work-up in Females with Venous Thromboembolism in Association with Oral Contraceptive Use: Results, Strategy and Clinical Application of Testing

  2017cites this paper
• [Systemic lupus erythematosus and contraception: A systematic literature review].

  2017cites this paper
• Efficacy and safety of warfarin treatment in venous thromboembolic disease

  2017cites this paper
• Tabagismo e uso de anticoncepcionais orais relacionados a fenômenos tromboembólicos: relato de caso e revisão de literatura

  2017cites this paper
• Genomische Diagnostik thrombophiler Gerinnungsstörungen bei Frauen - Klinische Relevanz

  2017cites this paper
• A Review of Recent Findings for Obstetricians about Combined Oral Contraceptive Pills

  2017cites this paper
• Review Article Oral contraceptives and oral health: an insight

  2016cites this paper
• Hemostatic effects of two desogestrel-containing combined oral contraceptive regimens: a multinational, multicenter, randomized, open-label study.

  2016cites this paper
• Venous thromboembolism and hormonal contraception

  2016cites this paper
• Obtaining causal estimates of therapeutic effects in observational studies : the usefulness and validity of physician’s preference as an instrumental variable

  2016cites this paper
• Risk Characteristics of Venous Thromboembolism in Chinese Patients

  2016cites this paper
• Causes of venous thrombosis

  2016cites this paper
• Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone® and ethinyl estradiol.

  2016cites this paper
• Anti-androgen contraceptive pills and higher risk of venous thromboembolism.

  2016cites this paper
• Androgen excess: Investigations and management.

  2016cites this paper
• The Sexual Acceptability of Contraception: Reviewing the Literature and Building a New Concept

  2016cites this paper
• The pill and thrombosis

  2016cites this paper
• Hormonal Contraception Use is Common Among Patients with Inflammatory Bowel Diseases and an Elevated Risk of Deep Vein Thrombosis

  2016cites this paper
• Instrumental variable analysis as a complementary analysis in studies of adverse effects: venous thromboembolism and second‐generation versus third‐generation oral contraceptives

  2016cites this paper
• Venous thromboembolism with special focus on genetic and potential acquired risk factors

  2016cites this paper
• Drug Information Rounds

  2015cites this paper
• Comparative Study of the Effects of Combined Oral Contraceptives in Hemostatic Variables

  2015cites this paper
• Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome

  2015cites this paper
• Hormonal Contraceptives and Cerebral Venous Thrombosis Risk: A Systematic Review and Meta-Analysis

  2015cites this paper
• Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review

  2015cites this paper
• Hormonal Contraception : New Insights on the Risk of Venous Thromboembolism

  2015cites this paper
• Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome

  2015cites this paper
• Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome

  2015cites this paper
• Combined oral contraceptives and risk of venous thromboembolism: there is higher risk in new generations compared to second generations, but paradoxically not in norgestimate-containing-pills

  2015cites this paper
• Oral Contraceptives and the Risk of Venous Thromboembolism

  2015influential citation
• Cerebral Venous Sinus Thrombosis in Users of a Hormonal Vaginal Ring

  2015cites this paper
• Contraception après IVG au CHU de Bordeaux : comparaison 2009 - 2013

  2015cites this paper
• Current use of oral contraceptives and the risk of first-ever ischemic stroke: A meta-analysis of observational studies.

  2015cites this paper
• How to avoid venous thromboembolism in women at increased risk--with special focus on low-risk periods.

  2015cites this paper
• Risk of venous thrombosis associated with different types of combined oral contraceptive preparations.

  2014cites this paper
• An update on progestins and venous thromboembolism risk: What clinicians need to know*

  2014cites this paper
• [Selected aspects of oral contraception side effects].

  2014cites this paper
• Combined oral contraceptives increase risk of venous thrombosis according to oestrogen dose and type of progestogen

  2014cites this paper
• The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort study

  2014influential citation
• MED-3950 5.-ÅRSOPPGAVEN PROFESJONSSTUDIET I MEDISIN VED UNIVERSITETET I TROMSØ - NORGES ARKTISKE UNIVERSITET

  2014cites this paper
• LEVONORGESTREL AND ETHINYLESTRADIOL ON KIDNEY FUNCTION

  2014cites this paper